SLC2A1 and neoplasm: Subcutaneous injection of IH tumor sphere cells into immunocompromised NOD-SCID mice resulted in GLUT-1-positive and CD31-positive tumors with the same cell proliferation, differentiation, and degeneration processes seen in human IH.